CH407117A - Verfahren zur Herstellung neuer Piperidinderivate - Google Patents

Verfahren zur Herstellung neuer Piperidinderivate

Info

Publication number
CH407117A
CH407117A CH126562A CH126562A CH407117A CH 407117 A CH407117 A CH 407117A CH 126562 A CH126562 A CH 126562A CH 126562 A CH126562 A CH 126562A CH 407117 A CH407117 A CH 407117A
Authority
CH
Switzerland
Prior art keywords
preparation
piperidine derivatives
new piperidine
new
derivatives
Prior art date
Application number
CH126562A
Other languages
English (en)
Inventor
Kurt Dr Freter
Merz Herbert Dr Dipl-Chem
Karl Dr Zeile
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of CH407117A publication Critical patent/CH407117A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/26Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from polyamines and polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH126562A 1961-02-11 1962-02-02 Verfahren zur Herstellung neuer Piperidinderivate CH407117A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0061246 1961-02-11

Publications (1)

Publication Number Publication Date
CH407117A true CH407117A (de) 1966-02-15

Family

ID=6973130

Family Applications (1)

Application Number Title Priority Date Filing Date
CH126562A CH407117A (de) 1961-02-11 1962-02-02 Verfahren zur Herstellung neuer Piperidinderivate

Country Status (5)

Country Link
CH (1) CH407117A (de)
DE (1) DE1288090B (de)
FR (1) FR2118M (de)
GB (1) GB935410A (de)
NL (2) NL6818296A (de)

Also Published As

Publication number Publication date
NL6818296A (de) 1969-03-25
GB935410A (en) 1963-08-28
NL274602A (de)
DE1288090B (de) 1969-01-30
FR2118M (fr) 1963-11-04

Similar Documents

Publication Publication Date Title
AT258875B (de) Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate
AT244965B (de) Verfahren zur Herstellung neuer heterocyclischer Benzocycloheptan-Derivate
AT243259B (de) Verfahren zur Herstellung neuer Isoindolinonderivate
CH428767A (de) Verfahren zur Herstellung von 1-Phenyl-2-aminoäthanolderivaten
CH455828A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
AT240378B (de) Verfahren zur Herstellung neuer Carbaminsäurederivate
CH404674A (de) Verfahren zur Herstellung neuer 3-Alkenyl- und 3-Alkinyl-1-(5-nitrofurfuryliden-amino)-hydantoine
AT265520B (de) Verfahren zur Herstellung neuer Cephalosporinderivate
CH407119A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH437324A (de) Verfahren zur Herstellung neuer Triazinverbindungen
AT243795B (de) Verfahren zur Herstellung neuer Chinolizin-Derivate
AT251777B (de) Verfahren zur Herstellung neuer Hendekapeptide
CH423050A (de) Verfahren zur Herstellung neuer Diacylaminoanthrachinone
CH410950A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH405292A (de) Verfahren zur Herstellung neuer Homo-Steroide
CH450448A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH480356A (de) Verfahren zur Herstellung neuer Azaphenthiazinderivate
CH407117A (de) Verfahren zur Herstellung neuer Piperidinderivate
CH407120A (de) Verfahren zur Herstellung von neuen Piperidinderivaten
CH408003A (de) Verfahren zur Herstellung neuer quartärer Piperidiniumderivate
CH435256A (de) Verfahren zur Herstellung neuer Oxidosteroide
CH435257A (de) Verfahren zur Herstellung neuer Oxidosteroide
AT247327B (de) Verfahren zur Herstellung neuer Piperidinderivate
CH420167A (de) Verfahren zur Herstellung neuer N-Diphenylalkyl-norgranatan- und -nortropan-Derivate
CH401047A (de) Verfahren zur Herstellung neuer Östradiolderivate